Peripheral T-cell Lymphoma: Clinical Trials

2 trials for Peripheral T-cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1

Follow Peripheral T-cell Lymphoma: new trials by email Literature Review of Peripheral T-cell Lymphoma trials Research Report on Peripheral T-cell Lymphoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma
PD-1 blocking antibody, chidamide, lenalidomide and gemcitabine - Peripheral T-cell Lymphoma
Phase 4UnknownMingzhi Zhang1002019-09-012020-05-12
Treatment of Peripheral T-cell Lymphoma
GDPT regimen, CHOP regimen - Peripheral T-cell Lymphoma
Phase 4CompletedMingzhi Zhang1002011-08-012016-10-05

Narrower conditions

Lymphoma, T-Cell, Peripheral (2)

Broader conditions

Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoma, T-Cell (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)

Interventions

Gemcitabine (1)  ·  Lenalidomide (1)  ·  N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1)  ·  VAP-cyclo protocol (1)

Sponsors

Mingzhi Zhang (2)

Countries

China (2)

Top investigators

Mingzhi Zhang, Pro,Dr (1)

Results publications

PMID 28597542, PMID 32550864